Capromab pendetide

N/A

Report date: 2025/09/05 17:58:17

Base Information

Drug NameCapromab pendetide
Drug Alias NameCapromab卡罗单抗喷地肽Indium (111In) labeled capromab pendetide卡罗单抗卡普罗单抗 +[11] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionSingle-photon emission-computed tomography enhancersAnti-PSMA
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/10/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEusa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesCytogen Corp
Inactive CompaniesJohns Hopkins University
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksWikipediaDrugBankKEGG